Study ID | Study follow‐up (months) | NVX‐CoV2373 (n) | Placebo (n) | Critical outcomes | ||||||
Confirmed SARS‐CoV‐2 infection after complete vaccination | Confirmed symptomatic COVID‐19 after complete vaccination | Severe or critical COVID‐19 | All‐cause mortality | Systemic reactogenicity events | Any AE | SAE | ||||
Keech 2020 (NCT04368988) | 1.15 | 29 | 25 | * | * | * | * | * | ✓ | ✓ |
Dunkle 2021 (NCT04611802) | 2 | 19,965 | 9984 | * | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Formica 2021 (NCT04368988) | 1.15 | 258 | 257 | * | * | * | * | ✓ | ✓ | ✓ |
Heath 2021 (NCT04583995; EudraCT 2020‐004123‐16) | 13 | 7593 | 7594 | * | ✓ | ✓ | ✓ | * | ✓ | ✓ |
Shinde 2021 (NCT04533399; PACTR202009726132275) | 1.15 | 2206 | 2200 | * | ✓ | ✓ | * | ✓ | ✓ | ✓ |